{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:05:49Z","timestamp":1740146749699,"version":"3.37.3"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong","doi-asserted-by":"crossref","award":["2018B030311023, 2020A1515011176"],"award-info":[{"award-number":["2018B030311023, 2020A1515011176"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973775 and No.82004256"],"award-info":[{"award-number":["81973775 and No.82004256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973775 and No.82004256"],"award-info":[{"award-number":["81973775 and No.82004256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pilot Project of Integrated Traditional Chinese and Western Medicine Clinical Collaboration for Major and Difficult Diseases"},{"name":"National Administration of Traditional Chinese Medicine: 2019 Project of building evidence based practice capacity for TCM","award":["2019XZZX-ZL001"],"award-info":[{"award-number":["2019XZZX-ZL001"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Globally, non-small cell lung cancer (NSCLC) is the most common malignancy and its prognosis remains poor because of the lack of reliable early diagnostic biomarkers. The competitive endogenous RNA (ceRNA) network plays an important role in the tumorigenesis and prognosis of NSCLC. Tumor immune microenvironment (TIME) is valuable for predicting the response to immunotherapy and determining the prognosis of NSCLC patients. To understand the TIME-related ceRNA network, the RNA profiling datasets from the Genotype-Tissue Expression and The Cancer Genome Atlas databases were analyzed to identify the mRNAs, microRNAs, and lncRNAs associated with the differentially expressed genes. Weighted gene co-expression network analysis revealed that the brown module of mRNAs and the turquoise module of lncRNAs were the most important. Interactions among microRNAs, lncRNAs, and mRNAs were prognosticated using miRcode, miRDB, TargetScan, miRTarBase, and starBase databases. A prognostic model consisting of 13 mRNAs was established using univariate and multivariate Cox regression analyses and validated by the receiver operating characteristic (ROC) curve. The 22 immune infiltrating cell types were analyzed using the CIBERSORT algorithm, and results showed that the high-risk score of this model was related to poor prognosis and an immunosuppressive TIME. A lncRNA\u2013miRNA\u2013mRNA ceRNA network that included 69 differentially expressed lncRNAs (DElncRNAs) was constructed based on the five mRNAs obtained from the prognostic model. ROC survival analysis further showed that the seven DElncRNAs had a substantial prognostic value for the overall survival (OS) in NSCLC patients; the area under the curve was 0.65. In addition, the high-risk group showed drug resistance to several chemotherapeutic and targeted drugs including cisplatin, paclitaxel, docetaxel, gemcitabine, and gefitinib. The differential expression of five mRNAs and seven lncRNAs in the ceRNA network was supported by the results of the HPA database and RT-qPCR analyses. This comprehensive analysis of a ceRNA network identified a set of biomarkers for prognosis and TIME prediction in NSCLC.<\/jats:p>","DOI":"10.1371\/journal.pone.0260720","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T19:53:52Z","timestamp":1638474832000},"page":"e0260720","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer"],"prefix":"10.1371","volume":"16","author":[{"given":"Cai-Zhi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei-Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5990-2103","authenticated-orcid":true,"given":"Zhong-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Ling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0134-1435","authenticated-orcid":true,"given":"Li-Zhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"issue":"1","key":"pone.0260720.ref001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"RL Siegel","year":"2019","journal-title":"CA Cancer J. Clin"},{"issue":"5","key":"pone.0260720.ref002","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"KD Miller","year":"2019","journal-title":"CA Cancer J. Clin"},{"issue":"8","key":"pone.0260720.ref003","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Z Chen","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"pone.0260720.ref004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer","volume":"11","author":"P Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol"},{"volume-title":"SEER Cancer Statistics Review, 1975\u20132017","year":"2020","author":"NNA Howlader","key":"pone.0260720.ref005"},{"issue":"7","key":"pone.0260720.ref006","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.7150\/thno.28119","article-title":"Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)","volume":"9","author":"W Liang","year":"2019","journal-title":"Theranostics"},{"issue":"5","key":"pone.0260720.ref007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/M13-2316","article-title":"Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force","volume":"160","author":"HJ de Koning","year":"2014","journal-title":"Ann. Intern. Med"},{"issue":"8","key":"pone.0260720.ref008","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrc.2016.56","article-title":"Biomarker development in the precision medicine era: lung cancer as a case study","volume":"16","author":"AJ Vargas","year":"2016","journal-title":"Nature reviews. Cancer"},{"key":"pone.0260720.ref009","doi-asserted-by":"crossref","first-page":"103119","DOI":"10.1016\/j.critrevonc.2020.103119","article-title":"Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma","volume":"156","author":"G Lamberti","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"pone.0260720.ref010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc.2017.84","article-title":"Understanding and targeting resistance mechanisms in NSCLC","volume":"17","author":"J Rotow","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"pone.0260720.ref011","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer","volume":"379","author":"L Paz-Ares","year":"2018","journal-title":"New Engl. J. Med"},{"issue":"12","key":"pone.0260720.ref012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123851","article-title":"Acquired Resistance to PD-1\/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure","volume":"12","author":"R Pathak","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"pone.0260720.ref013","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1470-2045(19)30785-5","article-title":"Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study","volume":"21","author":"LV Sequist","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"pone.0260720.ref014","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.tranon.2018.04.006","article-title":"Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers","volume":"11","author":"I Catacchio","year":"2018","journal-title":"Transl. Oncol"},{"key":"pone.0260720.ref015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.lungcan.2017.08.005","article-title":"PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review","volume":"112","author":"R Brody","year":"2017","journal-title":"Lung Cancer"},{"issue":"10","key":"pone.0260720.ref016","doi-asserted-by":"crossref","first-page":"938","DOI":"10.7150\/jca.12286","article-title":"Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation","volume":"6","author":"S Rivas-Fuentes","year":"2015","journal-title":"J. Cancer"},{"issue":"3","key":"pone.0260720.ref017","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"L Salmena","year":"2011","journal-title":"Cell"},{"issue":"1","key":"pone.0260720.ref018","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-017-0680-1","article-title":"STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4","volume":"16","author":"H Wang","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"pone.0260720.ref019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-019-1107-y","article-title":"Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer","volume":"18","author":"J Yang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"pone.0260720.ref020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-019-0943-0","article-title":"Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer","volume":"18","author":"L Chen","year":"2019","journal-title":"Mol. Cancer"},{"issue":"9","key":"pone.0260720.ref021","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1111\/jcmm.15193","article-title":"To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer","volume":"24","author":"J Jiang","year":"2020","journal-title":"J. Cell. Mol. Med"},{"key":"pone.0260720.ref022","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3389\/fonc.2019.00935","article-title":"Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma","volume":"9","author":"N Liu","year":"2019","journal-title":"Frontiers in oncology"},{"issue":"6","key":"pone.0260720.ref023","first-page":"2402","article-title":"Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non-small cell lung cancer","volume":"42","author":"XW Wang","year":"2019","journal-title":"Oncol. Rep"},{"issue":"4","key":"pone.0260720.ref024","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00432-020-03161-6","article-title":"Candidate lncRNA-microRNA-mRNA networks in predicting non-small cell lung cancer and related prognosis analysis","volume":"146","author":"S Li","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"pone.0260720.ref025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2017.02.016","article-title":"Prognostic alternative mRNA splicing signature in non-small cell lung cancer","volume":"393","author":"Y Li","year":"2017","journal-title":"Cancer Lett"},{"issue":"1","key":"pone.0260720.ref026","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41467-017-01027-z","article-title":"Comprehensive analysis of normal adjacent to tumor transcriptomes","volume":"8","author":"D Aran","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"pone.0260720.ref027","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"G. Consortium","year":"2013","journal-title":"Nat. Genet"},{"issue":"20","key":"pone.0260720.ref028","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1158\/0008-5472.CAN-19-0400","article-title":"Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues","volume":"79","author":"JP Unfried","year":"2019","journal-title":"Cancer Res"},{"issue":"3","key":"pone.0260720.ref029","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s13167-019-00175-0","article-title":"Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer","volume":"10","author":"N Li","year":"2019","journal-title":"The EPMA journal"},{"issue":"4","key":"pone.0260720.ref030","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3747\/co.27.6049","article-title":"Real-world treatment patterns and survival in stage IV non-small-cell lung cancer in Canada","volume":"27","author":"SJ Seung","year":"2020","journal-title":"Current oncology (Toronto, Ont.)"},{"issue":"2","key":"pone.0260720.ref031","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jtho.2019.10.002","article-title":"Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC","volume":"15","author":"JE Gray","year":"2020","journal-title":"J. Thorac. Oncol"},{"issue":"24","key":"pone.0260720.ref032","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1093\/bioinformatics\/bty503","article-title":"Predicting miRNA-disease association based on inductive matrix completion","volume":"34","author":"X Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"2","key":"pone.0260720.ref033","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/bib\/bbx130","article-title":"MicroRNAs and complex diseases: from experimental results to computational models","volume":"20","author":"X Chen","year":"2019","journal-title":"Brief Bioinform"},{"issue":"4","key":"pone.0260720.ref034","first-page":"558","article-title":"Long non-coding RNAs and complex diseases: from experimental results to computational models","volume":"18","author":"X Chen","year":"2017","journal-title":"Brief Bioinform"},{"issue":"7","key":"pone.0260720.ref035","doi-asserted-by":"crossref","first-page":"e1007209","DOI":"10.1371\/journal.pcbi.1007209","article-title":"Ensemble of decision tree reveals potential miRNA-disease associations","volume":"15","author":"X Chen","year":"2019","journal-title":"PLoS Comp. Biol"},{"key":"pone.0260720.ref036","doi-asserted-by":"crossref","first-page":"105261","DOI":"10.1016\/j.knosys.2019.105261","article-title":"Predicting lncRNA\u2013miRNA interactions based on logistic matrix factorization with neighborhood regularized","volume":"191","author":"H Liu","year":"2020","journal-title":"Knowl-Based Syst"},{"issue":"3","key":"pone.0260720.ref037","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ygeno.2021.02.002","article-title":"Predicting lncRNA-miRNA interactions based on interactome network and graphlet interaction","volume":"113","author":"L Zhang","year":"2021","journal-title":"Genomics"},{"issue":"3","key":"pone.0260720.ref038","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12539-021-00458-z","article-title":"Using Network Distance Analysis to Predict lncRNA-miRNA Interactions","volume":"13","author":"L Zhang","year":"2021","journal-title":"Interdisciplinary sciences, computational life sciences"},{"key":"pone.0260720.ref039","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014A target for novel cancer therapy","volume":"63","author":"R Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev"},{"issue":"5","key":"pone.0260720.ref040","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.21037\/jtd.2019.05.69","article-title":"The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer","volume":"11","author":"X Wang","year":"2019","journal-title":"J. Thorac. Dis"},{"issue":"3","key":"pone.0260720.ref041","doi-asserted-by":"crossref","first-page":"e1006701","DOI":"10.1371\/journal.pcbi.1006701","article-title":"New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx","volume":"15","author":"M Mounir","year":"2019","journal-title":"PLoS Comp. Biol"},{"issue":"6","key":"pone.0260720.ref042","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ng.2287","article-title":"The Pediatric Cancer Genome Project","volume":"44","author":"JR Downing","year":"2012","journal-title":"Nat. Genet"},{"key":"pone.0260720.ref043","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1471-2105-12-449","article-title":"ReCount: a multi-experiment resource of analysis-ready RNA-seq gene count datasets","volume":"12","author":"AC Frazee","year":"2011","journal-title":"BMC Bioinformatics"},{"issue":"18","key":"pone.0260720.ref044","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1038\/s41388-018-0650-0","article-title":"Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4\/6 inhibition in patient-derived models of pancreatic cancer","volume":"38","author":"ES Knudsen","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"pone.0260720.ref045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41419-020-2230-9","article-title":"circRNA-002178 act as a ceRNA to promote PDL1\/PD1 expression in lung adenocarcinoma","volume":"11","author":"J Wang","year":"2020","journal-title":"Cell Death Dis"},{"issue":"5","key":"pone.0260720.ref046","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2217\/imt.13.33","article-title":"T-cell tolerance in cancer","volume":"5","author":"R Nurieva","year":"2013","journal-title":"Immunotherapy"},{"issue":"9","key":"pone.0260720.ref047","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"N Nagarsheth","year":"2017","journal-title":"Nature reviews. Immunology"},{"issue":"44","key":"pone.0260720.ref048","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1038\/sj.onc.1210466","article-title":"Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis","volume":"26","author":"M Kanehira","year":"2007","journal-title":"Oncogene"},{"issue":"14","key":"pone.0260720.ref049","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1158\/0008-5472.CAN-10-0255","article-title":"Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells","volume":"70","author":"Y Harada","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"pone.0260720.ref050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","article-title":"Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas","volume":"72","author":"H Okayama","year":"2012","journal-title":"Cancer Res"},{"issue":"3","key":"pone.0260720.ref051","first-page":"1075","article-title":"DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20\/CCR6 signaling pathway","volume":"42","author":"W Guo","year":"2019","journal-title":"Oncol. Rep"},{"issue":"3","key":"pone.0260720.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw231","article-title":"Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma","volume":"109","author":"M \u00c7eliktas","year":"2017","journal-title":"J. Natl. Cancer Inst"},{"issue":"7656","key":"pone.0260720.ref053","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature22359","article-title":"CPS1 maintains pyrimidine pools and DNA synthesis in KRAS\/LKB1-mutant lung cancer cells","volume":"546","author":"J Kim","year":"2017","journal-title":"Nature"},{"issue":"4","key":"pone.0260720.ref054","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1086\/302328","article-title":"COL9A3: A third locus for multiple epiphyseal dysplasia","volume":"64","author":"P Paassilta","year":"1999","journal-title":"Am. J. Hum. Genet"},{"issue":"2","key":"pone.0260720.ref055","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/bjc.2013.326","article-title":"Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas","volume":"109","author":"SV Ivanov","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"6","key":"pone.0260720.ref056","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"A Alonso","year":"2004","journal-title":"Cell"},{"issue":"50","key":"pone.0260720.ref057","doi-asserted-by":"crossref","first-page":"39260","DOI":"10.1074\/jbc.M110.174706","article-title":"PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells","volume":"285","author":"A Carlucci","year":"2010","journal-title":"J. Biol. Chem"},{"key":"pone.0260720.ref058","doi-asserted-by":"crossref","first-page":"4686132","DOI":"10.1155\/2019\/4686132","article-title":"PTPN21 Overexpression Promotes Osteogenic and Adipogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells but Inhibits the Immunosuppressive Function","volume":"2019","author":"H Wang","year":"2019","journal-title":"Stem Cells Int"},{"key":"pone.0260720.ref059","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fonc.2020.00526","article-title":"miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer","volume":"10","author":"Y Li","year":"2020","journal-title":"Front Oncol"},{"key":"pone.0260720.ref060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13578-018-0202-x","article-title":"Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer extracellular vesicles","volume":"8","author":"C Li","year":"2018","journal-title":"Cell & bioscience"},{"issue":"1","key":"pone.0260720.ref061","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2014.05.084","article-title":"MicroRNA-429 induces tumorigenesis of human non-small cell lung cancer cells and targets multiple tumor suppressor genes","volume":"450","author":"Y Lang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"27","key":"pone.0260720.ref062","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2217\/fon-2018-0155","article-title":"Roles of miR-200 family members in lung cancer: more than tumor suppressors","volume":"14","author":"C Liu","year":"2018","journal-title":"Future oncology (London, England)"},{"issue":"6","key":"pone.0260720.ref063","first-page":"5193","article-title":"MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer","volume":"17","author":"A Grenda","year":"2019","journal-title":"Oncol. Lett"},{"issue":"6","key":"pone.0260720.ref064","first-page":"6261","article-title":"Silencing long intergenic non-coding RNA 00707 enhances cisplatin sensitivity in cisplatin-resistant non-small-cell lung cancer cells by sponging miR-145","volume":"18","author":"H Zhang","year":"2019","journal-title":"Oncol. Lett"},{"key":"pone.0260720.ref065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2018.11.032","article-title":"The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR","volume":"443","author":"M Xie","year":"2019","journal-title":"Cancer Lett"},{"key":"pone.0260720.ref066","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2018.01.060","article-title":"Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells","volume":"420","author":"K Li","year":"2018","journal-title":"Cancer Lett"},{"key":"pone.0260720.ref067","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopha.2017.08.057","article-title":"LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC)","volume":"95","author":"R He","year":"2017","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"pone.0260720.ref068","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2147\/CMAR.S170783","article-title":"Association between lncRNA CASC8 polymorphisms and the risk of cancer: a meta-analysis","volume":"10","author":"Z Cui","year":"2018","journal-title":"Cancer Manag. Res"},{"issue":"6","key":"pone.0260720.ref069","article-title":"Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity","volume":"13","author":"L Hu","year":"2016","journal-title":"Int. J. Env. Res. Public Health"},{"issue":"5","key":"pone.0260720.ref070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters","volume":"16","author":"G Yu","year":"2012","journal-title":"OMICS: A Journal of Integrative Biology"},{"key":"pone.0260720.ref071","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"P Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"pone.0260720.ref072","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1756-0500-2-142","article-title":"Network module detection: Affinity search technique with the multi-node topological overlap measure","volume":"2","author":"A Li","year":"2009","journal-title":"BMC research notes"},{"issue":"10","key":"pone.0260720.ref073","doi-asserted-by":"crossref","first-page":"16811","DOI":"10.18632\/oncotarget.15161","article-title":"Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma","volume":"8","author":"JH Zeng","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"pone.0260720.ref074","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"AM Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"3","key":"pone.0260720.ref075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mc.2940010303","article-title":"Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral Harvey ras","volume":"1","author":"P Amstad","year":"1988","journal-title":"Mol. Carcinog"},{"issue":"4","key":"pone.0260720.ref076","first-page":"637","article-title":"Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay","volume":"15","author":"YC Lee","year":"1985","journal-title":"Jap. J. Clin. Oncol"},{"issue":"23","key":"pone.0260720.ref077","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/sj.gt.3301331","article-title":"Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice","volume":"7","author":"YA Zhang","year":"2000","journal-title":"Gene Ther"},{"issue":"28","key":"pone.0260720.ref078","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1038\/sj.onc.1208669","article-title":"Oxidized guanine lesions and hOgg1 activity in lung cancer","volume":"24","author":"E Mambo","year":"2005","journal-title":"Oncogene"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:40:54Z","timestamp":1699886454000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260720"}},"subtitle":[],"editor":[{"given":"Qi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":78,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0260720","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,12,2]]}}}